Advertisement
Singapore markets closed
  • Straits Times Index

    3,224.01
    -27.70 (-0.85%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • Dow

    39,760.08
    +477.75 (+1.22%)
     
  • Nasdaq

    16,399.52
    +83.82 (+0.51%)
     
  • Bitcoin USD

    70,672.26
    -584.39 (-0.82%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.51
    +20.53 (+0.26%)
     
  • Gold

    2,232.10
    +19.40 (+0.88%)
     
  • Crude Oil

    82.48
    +1.13 (+1.39%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • Nikkei

    40,168.07
    -594.66 (-1.46%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • FTSE Bursa Malaysia

    1,530.60
    -7.82 (-0.51%)
     
  • Jakarta Composite Index

    7,288.81
    -21.28 (-0.29%)
     
  • PSE Index

    6,903.53
    +5.36 (+0.08%)
     

Antibiotics Market to Reach USD 39.06 Billion by 2027 at 2.1% CAGR; Surging Cases of Bacterial Infections to Incite Development, states Fortune Business Insights™

Key Prominent Players Covered in the Antibiotics Market Research Report Are Pfizer Inc., GlaxoSmithKline plc, Merck & Co., Inc., Sandoz, Daiichi Sankyo Company, Limited, Taisho Pharmaceutical Holdings, Melinta Therapeutics and other key market players.

Pune, India, Jan. 14, 2021 (GLOBE NEWSWIRE) -- The global antibiotics market size is expected to reach USD 39.06 billion in 2027 at a CAGR of 2.1% during the forecast period. The increasing R&D for the development of antimicrobials in multidrug-resistant bacteria is expected to have a tremendous impact on the global market, states Fortune Business Insights, in a report. The market size stood at USD 43.30 billion in 2019.

Increasing Cases of Bacterial Infections to Boost Market

The increasing cases of bacterial infections will spur demand for antimicrobials, which, in turn, will augur well for the market. The rising incidence of tuberculosis, malaria, pneumonia, bacterial skin infections, urinary tract infections (UTI), and others will bolster the market's healthy growth during the forecast period. As per the estimates of WHO, the worldwide prevalence of tuberculosis was 10 million in 2019.

ADVERTISEMENT

According to the Centers for Disease Control and Prevention, 1.7 million HAIs occur every year in the U.S., 32% of which are hospital-acquired UTIs. The increasing government efforts to prevent hospital-acquired infections (HAI), catheter, and ventilator-associated infections will create lucrative opportunities for the market in the forthcoming years.


Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/antibiotics-market-104583


Adoption of Digital Health Technologies to Promote Growth Amid Coronavirus

The declined patient volume in standalone clinics and hospitals has forced doctors to adopt digital health technologies to sustain their business. Pharmaceuticals and medical devices companies have incurred huge losses due to the economic crisis caused by the pandemic. Moreover, dopped sales observed by key manufacturers can simultaneously dampen the growth of the market. For instance, nine months of Pfizer’s Zithromax sales decreased by 14.2% in 2020 compared to 2019. Similarly, Cubicin, manufactured by Merck & Co., Inc., witnessed a decline of 44.0% in sale during nine months of 2020 as compared to the previous year

Substantial R&D Investments by Major Companies to Consolidate Business

Prominent companies such as Merck & Co., Inc, Sandoz, Taisho Pharmaceutical Holdings, Daiichi Sankyo Company, Limited are investing in R&D to strengthen their position in the industry. Moreover, the increasing approvals for innovative therapies by the FDA can spur lucrative opportunities for the market. For instance, in August 2019, TB Alliance, a non-profit organization, received FDA approval for Pretomanid, as part of combination therapy with linezolid and bedaquiline to treat TB.


Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/antibiotics-market-104583


Heavy Demand for Antibiotics to Contribute Growth in Asia Pacific

The market in Asia Pacific is expected to hold the largest share during the forecast period due to the high consumption of antibiotics. According to an article published in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS), China, India, and Pakistan witnessed a rise of 103%, 79%, and 69%, respectively, in antibiotic consumption during 2000-2015. The growing prevalence of bacterial infections coupled with the high use of antibiotics will spur lucrative opportunities for the Asia Pacific market.


Quick Buy - Antibiotics Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/104583


Key Development:

January 2020: Wockhardt announced that it had received approval from The Drug Controller General of India (DCGI) for Emrok (injectable) and Emrok O (oral) in acute bacterial skin and skin structure infections, including diabetic foot infections.


The Report Lists the Key Players in the Antibiotics Market:

  • Pfizer Inc. (New York, U.S.)

  • GlaxoSmithKline plc (Brentford, U.K.)

  • Merck & Co., Inc. (New Jersey, U.S.)

  • Sandoz (Novartis AG) (Holzkirchen, Germany)

  • Daiichi Sankyo Company, Limited (Tokyo, Japan)

  • Taisho Pharmaceutical Holdings (Tokyo, Japan)

  • Melinta Therapeutics (New Jersey, U.S.)

  • Other Prominent Players


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/antibiotics-market-104583


Table of Contents:

  • Introduction

    • Research Scope

    • Market Segmentation

    • Research Methodology

    • Definitions and Assumptions

  • Executive Summary

  • Market Dynamics

    • Market Drivers

    • Market Restraints

    • Market Opportunities

  • Key Insights

    • Prevalence of Key Bacterial Infections– For Key Countries/ Regions

    • Antimicrobial Resistance Statistics – For Key Countries/ Regions

    • Pipeline Snapshot

    • New Product Launches

    • Key Industry Developments – Partnerships, Mergers, & Acquisitions

    • Impact of COVID-19 Pandemic on Antibiotics Market

  • Global Antibiotics Market Analysis, Insights and Forecast, 2016-2027

    • Key Findings / Summary

    • Market Analysis, Insights and Forecast – By Drug Class

      • Cephalosporin

      • Penicillins

      • Fluoroquinolones

      • Macrolides

      • Others

    • Market Analysis, Insights and Forecast – By Route of Administration

      • Oral

      • Parenteral

    • Market Analysis, Insights and Forecast – By Distribution Channel

      • Hospital Pharmacy

      • Retail Pharmacy

      • Online Pharmacy

    • Market Analysis, Insights and Forecast – By Region

      • North America

      • Europe

      • Asia Pacific

      • Latin America

      • Middle East & Africa


TOC Continued….!


Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/antibiotics-market-104583


SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:

  • Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies

  • Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.

  • Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility

  • Number of procedures and average price of procedures

  • Replacement rate and pricing of capital equipment

  • Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities

  • Market & technological trends, new product developments, product pipeline.


Have a Look at Related Reports:

Bone Void Fillers Market Share & Industry Analysis, By Type (Demineralized Bone Matrix (DBM), Collagen Matrix, Calcium Sulfate, Tri-calcium Phosphate, and Others), By Form (Gel, Granules, Paste, Putty, and Others), By End User (Hospitals, Specialty Clinics and Others), and Regional Forecast, 2020-2027

Intensive Care Unit (ICU) Equipment Market Share and Covid-19 Impact Analysis, By Product (Beds, Ventilators, Pulse Oximeters, Dialysis Equipment, and Others), By Patient (Adult and Pediatric), By Application (Neurology, Cardiology, Respiratory, Renal, Oncology, Trauma, and Others), By End-User (Hospitals, Specialty Clinics, and Others) and Regional Forecast, 2020-2027

Bone Graft Substitutes Market Share & Industry Analysis, By Type (Autograft, Allograft, Demineralized bone matrix (DBM), Synthetic, Xenograft), By Application (Spinal Fusion, Joint Reconstruction, Foot & Ankle, Others), By End User (Hospitals, Specialty Clinics) and Regional Forecast, 2020-2027

Telerehabilitation Market Share and Covid-19 Impact Analysis, By Type (Products, Services), By Application (Occupational Therapy, Physical Therapy, Chronic Diseases, and Others), By End-User (Healthcare Facilities and Homecare); and Regional Forecast, 2020-2027

Ventilator Market Share & Covid-19 Impact Analysis, By Type (Adult, and Paediatric & Neonatal), By Interface (Invasive, and Non-invasive), By End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2020-2027


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs


Press Release: https://www.fortunebusinessinsights.com/press-release/global-antibiotics-market-10421